Crossmark Global Holdings Inc. Has $840,000 Stake in Align Technology, Inc. (NASDAQ:ALGN)

Crossmark Global Holdings Inc. trimmed its stake in Align Technology, Inc. (NASDAQ:ALGN) by 1.6% during the second quarter, Holdings Channel reports. The fund owned 3,477 shares of the medical equipment provider’s stock after selling 58 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Align Technology were worth $840,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Moody National Bank Trust Division raised its position in shares of Align Technology by 1.8% in the first quarter. Moody National Bank Trust Division now owns 2,107 shares of the medical equipment provider’s stock valued at $691,000 after purchasing an additional 38 shares during the period. Mather Group LLC. grew its stake in Align Technology by 52.5% in the 2nd quarter. Mather Group LLC. now owns 122 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 42 shares during the last quarter. Crewe Advisors LLC raised its holdings in Align Technology by 36.8% in the 2nd quarter. Crewe Advisors LLC now owns 171 shares of the medical equipment provider’s stock worth $41,000 after acquiring an additional 46 shares during the period. Czech National Bank lifted its position in Align Technology by 0.5% during the 1st quarter. Czech National Bank now owns 12,532 shares of the medical equipment provider’s stock worth $4,109,000 after acquiring an additional 57 shares during the last quarter. Finally, Wedmont Private Capital boosted its holdings in Align Technology by 4.8% during the first quarter. Wedmont Private Capital now owns 1,250 shares of the medical equipment provider’s stock valued at $413,000 after acquiring an additional 57 shares during the period. 88.43% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Align Technology

In other Align Technology news, Director C Raymond Larkin, Jr. bought 6,500 shares of the firm’s stock in a transaction dated Thursday, August 15th. The shares were bought at an average price of $235.33 per share, for a total transaction of $1,529,645.00. Following the completion of the acquisition, the director now owns 28,247 shares of the company’s stock, valued at $6,647,366.51. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 0.62% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on ALGN. Robert W. Baird dropped their price objective on Align Technology from $370.00 to $325.00 and set an “outperform” rating on the stock in a research note on Monday, July 22nd. Stifel Nicolaus cut their price target on Align Technology from $400.00 to $350.00 and set a “buy” rating for the company in a report on Thursday, July 25th. StockNews.com cut Align Technology from a “buy” rating to a “hold” rating in a research report on Sunday. OTR Global reaffirmed a “mixed” rating on shares of Align Technology in a research report on Tuesday, June 4th. Finally, Evercore ISI reduced their price target on shares of Align Technology from $370.00 to $300.00 and set an “outperform” rating for the company in a report on Monday, June 10th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $306.88.

Align Technology Stock Up 0.9 %

Shares of ALGN stock opened at $237.22 on Friday. The company has a market capitalization of $17.86 billion, a P/E ratio of 39.08, a P/E/G ratio of 5.18 and a beta of 1.66. Align Technology, Inc. has a 12-month low of $176.34 and a 12-month high of $375.68. The firm has a 50-day moving average price of $234.66 and a 200 day moving average price of $272.25.

Align Technology (NASDAQ:ALGN) last posted its earnings results on Wednesday, July 24th. The medical equipment provider reported $2.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.32 by $0.09. The company had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $1.04 billion. Align Technology had a net margin of 11.34% and a return on equity of 14.07%. Align Technology’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.73 earnings per share. As a group, research analysts expect that Align Technology, Inc. will post 7.64 earnings per share for the current year.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.